CoChat

Smoking in Patients Receiving Psychotropic Medications: A Pharmacokinetic Perspective

The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.

Abstract

Many psychiatric patients smoke, and are believed to be heavier smokers than those without psychiatric disorders. Cigarette smoking is one of the environmental factors that contributes to interindividual variations in response to an administered drug. Polycyclic aromatic hydrocarbons (PAHs) present in cigarette smoke induce hepatic aryl hydrocarbon hydroxylases, thereby increasing metabolic clearance of drugs that are substrates for these enzymes. PAHs have been shown to induce 3 hepatic cytochrome P450 (CYP) isozymes, primarily CYP1A1, 1A2 and 2E1. Drug therapy can also be affected pharmacodynamically by nicotine. The most common effect of smoking on drug disposition in humans is an increase in biotransformation rate, consistent with induction of drug-metabolising enzymes. Induction of hepatic enzymes has been shown to increase the metabolism and to decrease the plasma concentrations of imipramine, clomipramine, fluvoxamine and trazodone. The effect of smoking on the plasma concentrations of amitriptyline and nortriptyline is variable. Amfebutamone (bupropion) does not appear to be affected by cigarette smoking. Smoking is associated with increased clearance of tiotixene, fluphenazine, haloperidol and olanzapine. Plasma concentrations of chlorpromazine and clozapine are reduced by cigarette smoking. Clinically, reduced drowsiness in smokers receiving chlorpromazine, and benzodiazepines, compared with nonsmokers has been reported. Increased clearance of the benzodiazepines alprazolam, lorazepam, oxazepam, diazepam and demethyl-diazepam is found in cigarette smokers, whereas chlordiazepoxide does not appear to be affected by smoking. Carbamazepine appears to be minimally affected by cigarette smoke, perhaps because hepatic enzymes are already stimulated by its own autoinductive properties. Cigarette smoking can affect the pharmacokinetic and pharmacodynamic properties of many psychotropic drugs. Clinicians should consider smoking as an important factor in the disposition of these drugs.

Overview

Integrity signals

Registry

Crossref · 10.2165/00023210-200115060-00005

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 93 references

Research works printed but not linked: 8

  1. Shimada, 1994, J Pharmacol Exp Ther, 270, 414
  2. Luczynska, 1983, Methods Find Exp Clin Pharmacol, 5, 479
  3. Miller, 1990, Clin Pharm, 9, 125
  4. Vinarova, 1984, Biol Psychiatry, 19, 1265
  5. Stimmel, 1983, J Clin Psychiatry, 44, 420
  6. Kondo, 1996, Psychopharmacology, 127, 311, 10.1007/bf02806008 · doi:10.1007/bf02806008
  7. Norman, 1981, Clin Pharmacol, 229-, 33
  8. Desmond, 1979, N Engl J Med, 300, 199

Cited by

See all 306

Metadata

Authors
Desai, H. D., Seabolt, J., & Jann, M. W.
Affiliations
  • Mercer University (US)
  • University of Illinois Chicago (US)
Corresponding author
Jann, Michael W.
Venue
CNS Drugs
Published
2001
Volume
15
Issue
6
Pages
469-494
ISSN
1172-7047 (ISSN-L)
OpenAlex
W179281078
Cited by
253
References
92
Citations by year
2026: 4 · 2025: 6 · 2024: 5 · 2023: 5 · 2022: 9 · 2021: 11 · 2020: 28 · 2019: 13 · 2018: 7 · 2017: 14 · 2016: 12 · 2015: 13 · 2014: 7 · 2013: 11 · 2012: 9
FWCI
1.03
Type
journal article
Language
en
Open access
closed
Locations
  • CNS Drugs (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords
cigarette smoking, psychotropic drugs, drug metabolism, polycyclic aromatic hydrocarbons, cytochrome P450 induction, aryl hydrocarbon hydroxylase, drug-drug interactions, imipramine, clomipramine, fluvoxamine, trazodone, amitriptyline, nortriptyline, bupropion, antipsychotic drugs, chlorpromazine, clozapine, benzodiazepines, carbamazepine, plasma drug concentration
MeSH terms
Animals, Mental Disorders, Drug Interactions, Humans, Psychotropic Drugs, Smoking

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Smoking in Patients Receiving Psychotropic Medications: A Pharmacokinetic Perspective. https://app.cochat.ai/papers/10.2165/00023210-200115060-00005
The paper
Desai, H. D., Seabolt, J., & Jann, M. W. (2001). Smoking in Patients Receiving Psychotropic Medications: A Pharmacokinetic Perspective. CNS Drugs. https://doi.org/10.2165/00023210-200115060-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.